There is a tremendous craze among the fans regarding Mohanlal starrer 'Drishyam 3'. There are still 11 days left for the release of the film, but advance bookings have already started breaking records. The film has received a great response especially in America, where 1000 tickets were sold in just 97 hours. According to reports, despite limited pre-sales, the film has earned more than Rs 2 crore in advance worldwide. The popularity of 'Drishyam' franchise and the star power of Mohanlal have brought the film to the center of discussion even before its release.
'Drishyam 3' has made a great start in terms of advance booking in America. According to reports, the film sold 1000 tickets in just 97 hours for the premiere shows on May 20. With this, it has become the second Malayalam film to reach this figure fastest after 'L2: Empuraan'. The film has also earned a gross of about 15 thousand dollars i.e. about Rs 14.16 lakh at the US box office through pre-sales.
According to the film's US distributor 'Pratyangira Cinemas', 'Drishyam 3' has taken advance bookings of more than 25 thousand dollars for the entire opening weekend in America. Interestingly, the full-fledged booking of the film has not even started yet. At present, ticket sales of only fan shows have been opened in Kerala, yet opening day pre-sales across the world have crossed Rs 2 crore. It is clear from this that there is tremendous excitement among the audience about the film.
The 'Drishyam' franchise is already counted among the most popular thriller series of Indian cinema. In such a situation, the expectations of the audience regarding the third part are very high. Especially the market of Malayalam films is growing rapidly in foreign countries and America has now become an important market for Mollywood films. Trade experts believe that when the entire advance booking opens, 'Drishyam 3' can break many big records. There is a tremendous discussion on social media about the film.
Contact to : xlf550402@gmail.com
Copyright © boyuanhulian 2020 - 2023. All Right Reserved.